Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NORA: Metronomic Oral Vinorelbine and Cisplatin in Locally Advanced NSCLC
NCT02709720Phase 2Completed
- Sponsor
- Fundación GECP
- Start
- Apr 2016
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vinorelbine in non-small cell lung cancer (NSCLC), sponsored by Fundación GECP. Started Apr 2016; status: completed.
02
Drugs
vinorelbine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02709720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02709720.